Wall Street analysts predict that Colgate-Palmolive (NYSE:CL) will post $0.71 earnings per share (EPS) for the current fiscal quarter, according to Zacks. Six analysts have provided estimates for Colgate-Palmolive’s earnings, with estimates ranging from $0.70 to $0.71. Colgate-Palmolive posted earnings per share of $0.72 during the same quarter last year, which indicates a negative year over year growth rate of 1.4%. The business is expected to report its next earnings results on Friday, October 25th.

On average, analysts expect that Colgate-Palmolive will report full year earnings of $2.84 per share for the current financial year, with EPS estimates ranging from $2.83 to $2.85. For the next financial year, analysts expect that the company will report earnings of $3.06 per share, with EPS estimates ranging from $3.00 to $3.13. Zacks Investment Research’s earnings per share averages are a mean average based on a survey of sell-side research analysts that cover Colgate-Palmolive.

Colgate-Palmolive (NYSE:CL) last released its quarterly earnings data on Friday, July 26th. The company reported $0.72 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $0.72. The company had revenue of $3.87 billion for the quarter, compared to analysts’ expectations of $3.88 billion. Colgate-Palmolive had a net margin of 14.77% and a negative return on equity of 10,821.98%. The business’s revenue was down .5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.77 EPS.

A number of equities analysts have recently issued reports on CL shares. Piper Jaffray Companies started coverage on shares of Colgate-Palmolive in a research report on Tuesday, August 13th. They set an “overweight” rating on the stock. Macquarie increased their price objective on shares of Colgate-Palmolive from $65.00 to $72.00 and gave the stock a “neutral” rating in a research report on Monday, April 29th. ValuEngine cut shares of Colgate-Palmolive from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. Morgan Stanley increased their price objective on shares of Colgate-Palmolive from $72.00 to $74.00 and gave the stock an “equal weight” rating in a research report on Monday, July 29th. Finally, UBS Group increased their price objective on shares of Colgate-Palmolive from $80.00 to $82.00 and gave the stock a “buy” rating in a research report on Monday, July 29th. One analyst has rated the stock with a sell rating, twelve have given a hold rating and six have issued a buy rating to the stock. The stock has an average rating of “Hold” and an average target price of $73.87.

In related news, insider Ian M. Cook sold 19,500 shares of the firm’s stock in a transaction dated Wednesday, May 29th. The shares were sold at an average price of $69.92, for a total value of $1,363,440.00. Following the transaction, the insider now owns 1,186,042 shares of the company’s stock, valued at approximately $82,928,056.64. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CFO Henning I. Jakobsen sold 33,854 shares of the firm’s stock in a transaction dated Wednesday, July 31st. The shares were sold at an average price of $73.45, for a total transaction of $2,486,576.30. Following the completion of the transaction, the chief financial officer now directly owns 73,693 shares in the company, valued at approximately $5,412,750.85. The disclosure for this sale can be found here. In the last ninety days, insiders sold 564,285 shares of company stock worth $40,530,290. 1.14% of the stock is owned by insiders.

A number of large investors have recently bought and sold shares of CL. Dimensional Fund Advisors LP boosted its position in Colgate-Palmolive by 3.4% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,737,377 shares of the company’s stock worth $103,412,000 after acquiring an additional 57,606 shares during the period. Geode Capital Management LLC boosted its position in Colgate-Palmolive by 7.9% during the 4th quarter. Geode Capital Management LLC now owns 10,540,277 shares of the company’s stock worth $626,200,000 after acquiring an additional 768,550 shares during the period. Nwam LLC acquired a new position in Colgate-Palmolive during the 1st quarter worth $211,000. City Holding Co. boosted its position in Colgate-Palmolive by 4.5% during the 1st quarter. City Holding Co. now owns 29,470 shares of the company’s stock worth $2,020,000 after acquiring an additional 1,273 shares during the period. Finally, Carroll Financial Associates Inc. boosted its position in Colgate-Palmolive by 4.8% during the 1st quarter. Carroll Financial Associates Inc. now owns 4,680 shares of the company’s stock worth $320,000 after acquiring an additional 216 shares during the period. Hedge funds and other institutional investors own 75.83% of the company’s stock.

CL stock opened at $72.61 on Friday. The stock has a market capitalization of $62.70 billion, a PE ratio of 24.45, a price-to-earnings-growth ratio of 4.70 and a beta of 0.76. The company’s 50-day moving average is $72.60 and its 200-day moving average is $70.03. The company has a debt-to-equity ratio of 32.25, a current ratio of 1.13 and a quick ratio of 0.78. Colgate-Palmolive has a 1 year low of $57.41 and a 1 year high of $76.41.

The firm also recently declared a quarterly dividend, which was paid on Thursday, August 15th. Investors of record on Thursday, July 18th were given a $0.43 dividend. The ex-dividend date was Wednesday, July 17th. This represents a $1.72 annualized dividend and a yield of 2.37%. Colgate-Palmolive’s payout ratio is 57.91%.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

Read More: Green Investing

Get a free copy of the Zacks research report on Colgate-Palmolive (CL)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.